Market Place
Sourcing Support
Kitov Expands Planned Phase 1/2 Trial of CM24 in Non-Small Cell Lung Cancer
09 Nov 2020 //
GLOBENEWSWIRE
Kitov Announces Initiation of Phase 1/2 Clinical Trial of NT219
09 Jul 2020 //
GLOBENEWSWIRE
Kitov Receives Notice of Intention to Grant a European Patent Covering CM24
08 Jul 2020 //
GLOBENEWSWIRE
Kitov Pharma Issues CEO Shareholder Letter Providing Business Update
02 Jul 2020 //
GLOBENEWSWIRE
Kitov Announces U.S. FDA Acceptance of INDA to Conduct Ph 1/2 Trial of NT219
22 May 2020 //
GLOBENEWSWIRE
Kitov Pharma Ltd. Announces Cash Proceeds of $6.5 M from Exercise of Warrants
20 Apr 2020 //
YAHOO
Kitov`s Expands Planned NT-219 Clinical Program for Difficult to Treat Cancers
25 Feb 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.